Diversity in Medicine: Are There Racial Differences in Treatment Out…

Houston Methodist DeBakey Heart and Vascular Center

C. Yancy

Intravenous Iron for Heart Failure: Where Is the Evidence?

28th Annual Heart Failure 2024: An Update on Therapy

I. Pina

Overview of Iron Deficiency in Heart Failure & Recognizing Iron Defi…

ACHL

M. Vaduganathan

Treatment of Iron Deficiency Across the Heart Failure Spectrum

ACHL

S. Gale

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Johnson & Johnson

M. Socinski, D. Waterhouse

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Johnson & Johnson

J. Heymach, M. Das

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

Photodynamic Therapy for Malignant Airway Disease

Fayez Kheir

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

Respiratory Tract, EBUS, Molecular Biomarker Testing in Non-Small Ce…

Houston Methodist

S. Roy-Chowdhuri

Diagnosis and Staging of Lung Cancer in the Era of Advanced Diagnost…

Cleveland Clinic Respiratory Institute

F. Almeida

2023 Update on Cardiac Amyloid

MUSC Cardiology

J. Griffin

ATS 2023 Insights: Climate Change and Cancer

ATS 2023 Insights

J. Schiller

Molecular Testing on EBUS-TBNA Specimen

Cleveland Clinic Respiratory Institute

A. C. Mehta

Iron Deficiency Cases and Panel Discussions

ACHL

A. Mardis, S. Gale, M. Vaduganathan

Updates on Cardiac Amyloidosis: A “Rare” Disease Hiding in Plain Sig…

Courage and Innovation Symposium: Heart Failure & Heart Transplantation

N. Sarswat

Clinical Presentation of Amyloidosis: Who to Suspect? - a 2022 Update

Scripps Health

R. Mohan

Practical Approaches to IV Iron Administration

ACHL

A. Mardis

Cardio-Oncology: The Interplay of Immunotherapy, Inflammation, and C…

UCLA Health

E. Yang

Role of Multimodality Imaging in Cardio-Oncology

Scripps Health

P. Parwani